Gardasil
Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant · Injection, Suspension · Intramuscular
No FDA structured label text is available for Gardasil. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Human Papillomavirus Type 6 L1 Capsid Protein Antigen in 2 products
- Human Papillomavirus Type 11 L1 Capsid Protein Antigen in 2 products
- Human Papillomavirus Type 16 L1 Capsid Protein Antigen in 2 products
- Human Papillomavirus Type 18 L1 Capsid Protein Antigen in 2 products
Gardasil NDC products (2)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 0006-4045 | Human Papillomavirus Type 6 L1 Capsid Protein Antigen 20 ug/.5mL; Human Papillomavirus Type 11 L1 Capsid Protein… Injection, Suspension | Merck Sharp & Dohme LLC | BLA |
| 0006-4109 | Human Papillomavirus Type 6 L1 Capsid Protein Antigen 20 ug/.5mL; Human Papillomavirus Type 11 L1 Capsid Protein… Injection, Suspension | Merck Sharp & Dohme LLC | BLA |
Frequently asked questions
Who makes Gardasil?
Gardasil is listed by 1 labeler in the FDA NDC directory, including Merck Sharp & Dohme LLC.